Anaesthetic implications for a malignant hyperthermia-susceptible fetus
- PMID: 33891324
- DOI: 10.1111/anae.15495
Anaesthetic implications for a malignant hyperthermia-susceptible fetus
Comment on
-
Malignant hyperthermia 2020: Guideline from the Association of Anaesthetists.Anaesthesia. 2021 May;76(5):655-664. doi: 10.1111/anae.15317. Epub 2021 Jan 5. Anaesthesia. 2021. PMID: 33399225
References
-
- Hopkins PM, Girard T, Dalay S, et al. Malignant hyperthermia 2020: guideline from the Association of Anaesthetists. Anaesthesia 2021; 76: 655-64.
-
- European Malignant Hyperthermia Group. Malignant hyperthermia during pregnancy. 2019. www.emhg.org/recommendations-1/mh-during-pregnancy (accessed 28/03/2021).
-
- Odor PM, Bampoe S, Moonesinghe SR, et al. General anaesthetic and airway management practice for obstetric surgery in England: a prospective, multicentre observational study. Anaesthesia 2021; 76: 460-71.
-
- Irwin MG, Wong GTC, Lam SW. Taking on TIVA: Debunking Myths and Dispelling Misunderstandings. Cambridge: Cambridge University Press; 2020.
-
- Dutta S, Karol MD, Cohen T, et al. Effects of dexmedetomidine on propofol requirements in healthy subjects. Journal of Pharmaceutical Sciences 2001; 90: 172-81.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources